ÂÜÀòÂÒÂ×

Steve Kaverman is an experienced professional in the pharmaceutical industry with a focus on drug discovery and formulation analysis. Currently serving as the Director of Dose Formulation Analysis at Inotiv since October 2018, Steve leads a team of scientists dedicated to performing dose formulation analysis to support drug development. Prior to this role, Steve held various positions at BASi, including Project Manager II and Project Manager I, and began their career at BASi as an Analyst I. Steve holds a Master of Science degree in Chemical Education and a Bachelor of Science degree in Pharmaceutical Sciences, both obtained from Purdue University.